Session 1: Feeding and infant development Breast-feeding and immune function

Proceedings of the Nutrition Society - Tập 66 Số 3 - Trang 384-396 - 2007
Lars Hanson1
1Department of Clinical Immunology, Göteborg University, Göteborg, Sweden

Tóm tắt

The newborn receives, via the placenta, maternal IgG antibodies against the microbes present in its surroundings, but such antibodies have a pro-inflammatory action, initiating the complement system and phagocytes. Although the host defence mechanisms of the neonate that involve inflammatory reactivity are somewhat inefficient, this defence system can still have catabolic effects. Breast-feeding compensates for this relative inefficiency of host defence in the neonate by providing considerable amounts of secretory IgA antibodies directed particularly against the microbial flora of the mother and her environment. These antibodies bind the microbes that are appearing on the infant's mucosal membranes, preventing activation of the pro-inflammatory defence. The major milk protein lactoferrin can destroy microbes and reduce inflammatory responses. The non-absorbed milk oligosaccharides block attachment of microbes to the infant's mucosae, preventing infections. The milk may contain anti-secretory factor, which is anti-inflammatory, preventing mastitis in mothers and diarrhoea in infants. Numerous additional factors in the milk are of unknown function, although IL-7 is linked to the larger size of the thymus and the enhanced development of intestinal Tγδ lymphocytes in breast-fed compared with non-breast-fed infants. Several additional components in the milk may help to explain why breast-feeding can reduce infant mortality, protecting against neonatal septicaemia and meningitis. It is therefore important to start breast-feeding immediately. Protection is also apparent against diarrhoea, respiratory infections and otitis media. There may be protection against urinary tract infections and necrotizing enterocolitis, and possibly also against allergy and certain other immunological diseases, and tumours. In conclusion, breast-feeding provides a very broad multifactorial anti-inflammatory defence for the infant.

Từ khóa


Tài liệu tham khảo

10.1099/0022-1317-72-7-1667

Zaman, 2007, Efficacy of anti-secretory factor in reducing severity and duration of acute and prolonged diarrhoeal illness in children 6–24 months of age – a placebo controlled trial, Acta Paediatrica

10.1136/bmj.299.6705.946

10.1002/bies.20423

Walterspiel, 1994, Secretory anti-Giardia lamblia antibodies in human milk: protective effect against diarrhea, Pediatrics, 93, 28, 10.1542/peds.93.1.28

10.1080/000163501750541219

10.1097/00006454-199110000-00008

Victora, 1990, Human Lactation 4. Breastfeeding Nutrition Infection and Infant Growth in Developed and Emerging Countries, 405

10.1203/00006450-200007000-00008

10.1111/j.1651-2227.2004.tb02754.x

10.3168/jds.S0022-0302(73)85216-6

10.1016/j.bbrc.2006.04.081

10.1067/mpd.2002.128890

10.1016/B0-72-160537-0/50004-9

10.1093/jn/135.5.1294

10.1542/peds.2005-1629

Strömqvist, 1995, Human milk kappa-casein and inhibition of Helicobacter pylori adhesion to human gastric mucosa, Journal of Pediatrics, 21, 288

10.1111/j.1651-2227.1996.tb14095.x

10.1016/S0140-6736(04)16210-7

10.1016/S0140-6736(83)90234-9

10.1016/j.vaccine.2006.10.025

10.1016/j.jpeds.2004.06.029

10.1097/00006454-200209000-00006

10.1080/08035250510027642

10.1016/S0022-3476(05)80607-9

10.1016/S0091-6749(03)02018-9

10.1136/fn.88.1.F11

10.1016/0003-9969(94)90026-4

10.1016/S0140-6736(97)10322-1

10.1016/j.jpeds.2004.04.054

10.1093/ajcn/80.3.722

10.1136/adc.2006.096826

10.1111/j.1651-2227.2004.tb00699.x

10.1111/j.1472-765X.2004.01631.x

1995, Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. WHO Collaborative Study Group on Oral Poliovirus Vaccination, Journal of Infectious Diseases, 95, 1097

10.1097/01.ede.0000152900.81355.00

10.1128/IAI.71.9.5149-5155.2003

Mata, 1969, Shigella infection in breast-fed Guatemalan Indian neonates, American Journal of Diseases of Children, 117, 142

Neeser, 1988, Specific and nonspecific inhibition of adhesion of oral actinomyces and streptococci to erythrocytes and polystyrene by caseinoglycopeptide derivatives, Infection and Immunity, 56, 3201, 10.1128/IAI.56.12.3201-3208.1988

10.1093/jn/127.5.980S

10.1099/00222615-47-9-837

10.1016/j.jclinepi.2004.12.007

10.1016/S0264-410X(03)00337-2

10.1136/adc.86.6.400

10.1056/NEJM198306093082304

Gillin, 1985, Cholate-dependent killing of Giardia lamblia by human milk, Infection and Immunity, 47, 619, 10.1128/IAI.47.3.619-622.1985

10.1097/00006454-199706000-00006

10.1016/j.micinf.2005.04.011

10.1038/oby.2004.190

Kramer, 2003, Infant growth and health outcomes associated with 3 compared with 6 mo of exclusive breastfeeding, American Journal of Clinical Nutrition, 78, 291, 10.1093/ajcn/78.2.291

10.1038/nri1393

10.1046/j.1365-3083.2003.01162.x

10.2105/AJPH.76.3.259

10.4049/jimmunol.170.8.4087

10.1111/j.1651-2227.1988.tb10726.x

10.1093/jnci/dji291

10.1001/jama.285.4.413

10.1111/j.1651-2227.1993.tb12597.x

Hanson, 1998, Non-breastfeeding – The most common immunodeficiency, Hong Kong Journal of Paediatrics, 3, 5

10.1367/A04-088R.1

10.1111/j.1651-2227.1975.tb03928.x

Adlerberth, 1999, Development of the Gastrointestinal Tract, 279

10.1203/00006450-198605000-00008

10.1093/infdis/153.4.715

10.1084/jem.191.10.1807

10.1159/000229246

10.1080/00365520601013754

Garofalo, 1999, Expression of functional immunomodulatory and anti-inflammatory factors in human milk, Clinics in Perinatology, 26, 361, 10.1016/S0095-5108(18)30057-5

10.1203/00006450-198902000-00021

10.1007/s004310051258

10.1007/978-1-4615-2548-6_8

10.1016/j.jpeds.2005.03.038

Bahl, 2005, Infant feeding patterns and risks of death and hospitalization in the first half of infancy: multicentre cohort study, Bulletin of the World Health Organization, 83, 418

10.1161/01.CIR.0000145165.80130.B5

Furukawa, 1993, Presence of platelet-activating factor-acetylhydrolase in milk, Journal of Lipid Research, 34, 1603, 10.1016/S0022-2275(20)36953-4

10.1111/j.1651-2227.2004.tb02636.x

Adinolfi, 1966, Serological properties of gamma-A antibodies to Escherichia coli present in human colostrum, Immunology, 10, 517

10.1038/sj.ijo.0803160

10.1016/S0074-7696(01)10003-3

10.1007/1-4020-3535-7_7

10.1046/j.1365-2958.2003.03327.x

10.1046/j.1365-2249.1999.00782.x

10.1159/000229177

10.1542/peds.2005-1496

Hanson, 2007, Textbook of Breastfeeding

10.1046/j.1365-2567.2003.01700.x

Korhonen, 1985, Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis, Infection and Immunity, 48, 486, 10.1128/IAI.48.2.486-491.1985

10.1038/35066006

10.1136/bmj.300.6716.11

Edde, 2001, Lactoferrin protects neonatal rats from gut-related systemic infection, American Journal of Physiology, 281, G1140

Duncan, 1993, Exclusive breast-feeding for at least 4 months protects against otitis media, Pediatrics, 91, 867, 10.1542/peds.91.5.867

Clemens, 1993, Breast-feeding and the risk of life-threatening rotavirus diarrhea: Prevention or postponement, Pediatrics, 92, 680, 10.1542/peds.92.5.680

10.1542/peds.113.5.e435

10.1093/oxfordjournals.aje.a009540

10.1542/peds.2004-1833

10.1016/S0022-3476(05)80424-X

10.1016/B0-72-160537-0/50006-2

Otnaess, 1983, Inhibition of enterotoxin from Escherichia coli and Vibrio cholerae by gangliosides from human milk, Infection and Immunity, 40, 563, 10.1128/IAI.40.2.563-569.1983

10.1074/jbc.M207744200

10.1093/aje/kwh338

10.1136/bmj.318.7194.1316

10.1007/978-1-4615-1371-1_57

10.1016/0140-6736(90)93304-8

10.1136/bmj.38978.699583.55

Togawa, 2002, Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance, American Journal of Physiology, 283, G187

10.1136/adc.2003.045682

10.1111/j.1365-2222.2005.02379.x

Holmgren, 1983, Receptor-like glycocompounds in human milk that inhibit classical and El Tor Vibrio cholerae cell adherence (hemagglutination), Infection and Immunity, 39, 147, 10.1128/IAI.39.1.147-154.1983

10.1136/adc.88.3.224

Silfverdal, 2007, Breastfeeding protects against more severe manifestations of clinical measles infection, Proceedings of the 12th International Conference of the International Society for Research of Human Milk and Lactation (ISRHML), Cambridge 2004

10.1016/S0022-3476(05)80327-0

10.1093/ajcn/82.6.1298

10.1016/S0022-3476(05)81787-1

Schroten, 1992, Inhibition of adhesion of S-fimbriated Escherichia coli to buccal epithelial cells by human milk fat globule membrane components: a novel aspect of the protective function of mucins in the nonimmunoglobulin fraction, Infection and Immunity, 60, 2893, 10.1128/IAI.60.7.2893-2899.1992

10.1136/adc.2005.074260

Kawakami, 1991, Isolation and function of a receptor for human lactoferrin in human fetal intestinal brush-border membranes, American Journal of Physiology, 261, G841

10.1016/S0140-6736(04)16198-9

10.1111/j.1651-2227.1984.tb09950.x

10.1128/IAI.68.10.5816-5823.2000

10.1016/S0065-230X(03)88302-1

10.1093/aje/kwi222

10.1016/S0022-3476(82)80753-1

10.1016/S0010-7824(97)00040-1

10.1080/09629359990559

Hanson, 2004, Immunobiology of Human Milk. How Breastfeeding Protects Babies

10.1054/midw.2001.0253

10.1111/j.1651-2227.2002.tb03305.x

10.1111/j.1651-2227.1990.tb11401.x

10.1002/ijc.21274

10.1126/science.8009224

10.1111/j.1651-2227.1994.tb12942.x

10.1016/S0022-3476(05)82652-6

10.1093/infdis/153.2.232

Gartner, 2005, Breastfeeding and the use of human milk, Pediatrics, 115, 496, 10.1542/peds.2004-2491

10.1590/S0036-36341999000400003

10.1084/jem.20050625

10.1542/peds.2005-2382

10.1542/peds.113.2.e81

10.1111/j.1651-2227.1989.tb11225.x

10.1136/bmj.319.7203.147

10.1111/j.1651-2227.1982.tb09449.x

10.1097/01.ede.0000181629.59452.95

10.1084/jem.146.5.1311

10.1542/peds.2004-2283

10.1017/S0021932000020484

10.1203/01.pdr.0000200805.45593.17

10.1542/peds.103.2.434

Newburg, 1999, Human milk glycoconjugates that inhibit pathogens, Current Medicinal Chemistry, 6, 117, 10.2174/0929867306666220207212739

10.1038/257797a0

10.1053/jhin.2001.1129

10.1146/annurev.nutr.25.050304.092553

10.1016/B978-012491543-5/50036-X

10.1016/0140-6736(90)91802-H

10.1016/S0022-3476(95)70395-0

10.1016/S0140-6736(87)90902-0

Plaut, 1978, Microbial IgA proteases, New England Journal of Medicine, 298, 1459, 10.1056/NEJM197806292982608